Skip to main content
TipRanks
Go Ultimate75% OFF

MANAC Chemical Partners Co.,Ltd (4360) AI Stock Analysis

0 Followers
JP:4360

MANAC Chemical Partners Co.,Ltd

(TSE/TYO:4360)

Select Model
Rating:71Outperform
Price Target:JPY 1,067.00â–²(8.43% Upside)
Action:reiterated
Date:11/12/26

The score is primarily driven by improved financial performance and a conservative balance sheet alongside an attractive low P/E. Offsetting these positives are meaningful historical volatility in earnings/cash flow and a mixed technical picture with negative MACD and the price below near-term moving averages.

Positive Factors
Revenue and Profitability RecoveryThe return to profitability alongside 14.5% revenue growth indicates renewed operating momentum and improved demand or product contribution. If maintained, stronger earnings can support reinvestment, customer development, and resilience over the next several quarters.
Negative Factors
High Earnings VolatilityThe sharp earnings swings across recent years make it difficult to judge the durability of the latest recovery. Such volatility can weaken forecasting confidence, complicate resource allocation, and leave future profitability more exposed to changes in business conditions.

MANAC Chemical Partners Co.,Ltd (4360) vs. iShares MSCI Japan ETF (EWJ)

-20%0%20%40%60%80%100%JP:4360+59.92%EWJ+15.69%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 8.17B
Dividend Yield
1.52%
Average Volume (3M)
7,183
Price to Earnings (P/E)
8.2
Beta (1Y)
0.97
Revenue Growth
19.58%
EPS Growth
―
Country
Japan
Employees
246
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals

MANAC Chemical Partners Co.,Ltd Business Overview & Revenue Model

Company Description

Operating primarily in Japan, MANAC Chemical Partners Co.,Ltd, along with its subsidiaries, undertakes the comprehensive development, manufacturing, sales, import, and export of industrial chemicals and pharmaceutical products. The company additional...

How the Company Makes Money

MANAC Chemical Partners makes money primarily by selling chemical products it manufactures to business customers (B2B). Revenue is generated through (1) product sales of specialty/fine chemicals (including functional materials and chemical intermedia...

MANAC Chemical Partners Co.,Ltd Financial Statement Overview

Summary

Fundamentals show a strong 2026 rebound: revenue growth (+14.5%), return to solid profitability, and operating/free cash flow turning positive. The balance sheet remains conservative with low debt versus equity. The main offset is high earnings and cash flow volatility across 2024–2026 (including a large net loss in 2025), which reduces confidence in sustainability.

Income Statement

70Positive

Balance Sheet

83Very Positive

Cash Flow

67Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue11.48B10.99B9.30B9.69B11.85B10.70B
Gross Profit2.85B2.50B1.47B1.82B2.81B2.43B
EBITDA1.50B1.11B-312.00M545.00M1.62B1.19B
Net Income983.00M781.00M-895.00M82.00M821.00M712.00M
Balance Sheet
Total Assets16.02B15.31B12.65B14.10B15.01B13.59B
Cash, Cash Equivalents and Short-Term Investments4.19B4.01B2.77B3.29B3.72B2.04B
Total Debt791.00M816.00M00290.00M291.00M
Total Liabilities4.32B4.00B2.34B2.85B3.97B3.29B
Stockholders Equity11.70B11.30B10.30B11.25B11.04B10.29B
Cash Flow
Free Cash Flow0531.00M-411.00M-593.00M1.40B30.00M
Operating Cash Flow02.15B108.00M-118.00M1.65B714.00M
Investing Cash Flow0-1.66B-489.00M-231.00M199.00M-422.00M
Financing Cash Flow0727.00M-126.00M-75.00M-125.00M-200.00M

MANAC Chemical Partners Co.,Ltd Technical Analysis

Technical Analysis SentimentPositive
Last Price984.00

Price Trends

50DMA981.11Positive
100DMA901.00Positive
200DMA902.32Positive

Market Momentum

MACD-4.89Positive
RSI52.35Neutral
STOCH81.23Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4360, the sentiment is Positive. The current price of 984.00 is above the 20-day moving average (MA) of 978.10, above the 50-day MA of 981.11, and above the 200-day MA of 902.32, indicating a bullish trend. The MACD of -4.89 indicates Positive momentum. The RSI at 52.35 is Neutral, neither overbought nor oversold. The STOCH value of 81.23 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4360.

MANAC Chemical Partners Co.,Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

JP:4360 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:4040JP:404079OutperformJPY 9.44B2.70―1.61%0.56%238.99%
JP:6568JP:656873OutperformJPY 9.15B11.24―2.78%12.39%22.04%
JP:4360JP:436071OutperformJPY 8.33B8.16―1.52%19.58%―
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
JP:4531JP:453159NeutralJPY 7.27B14.81―3.05%3.90%-31.32%
JP:4960JP:496059NeutralJPY 8.48B21.11―0.97%6.87%300.65%

* Basic Materials Sector Average

Performance Comparison

0%100%200%300%JP:4360JP:4040JP:4531JP:4960JP:6568Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:4360 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:4360MANAC Chemical Partners Co.,Ltd984.00346.0554.24%
JP:4040NANKAI CHEMICAL COMPANY LIMITED4040.001044.4534.87%
JP:4531Yuki Gosei Kogyo Co., Ltd.328.0052.9619.26%
JP:4960Chemipro Kasei Kaisya,Ltd.491.00167.4351.75%
JP:6568KNC Laboratories Co.,Ltd.1189.00102.099.39%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 12, 2026